vs

Side-by-side financial comparison of LIFETIME BRANDS, INC (LCUT) and TransMedics Group, Inc. (TMDX). Click either name above to swap in a different company.

LIFETIME BRANDS, INC is the larger business by last-quarter revenue ($204.1M vs $160.8M, roughly 1.3× TransMedics Group, Inc.). TransMedics Group, Inc. runs the higher net margin — 65.6% vs 8.9%, a 56.7% gap on every dollar of revenue. On growth, TransMedics Group, Inc. posted the faster year-over-year revenue change (32.2% vs -5.2%). TransMedics Group, Inc. produced more free cash flow last quarter ($19.0M vs $2.6M). Over the past eight quarters, TransMedics Group, Inc.'s revenue compounded faster (28.8% CAGR vs 19.8%).

Yum! Brands, Inc. is an American multinational fast food corporation. It was formed in 1977 as a subsidiary of PepsiCo, after the company acquired KFC, Pizza Hut, and Taco Bell. PepsiCo divested the brands in 1997, and these consolidated as Yum!. The company operates KFC, Pizza Hut, Taco Bell, Habit Burger & Grill, and several technology companies.

TransMedics Group, Inc. develops and commercializes innovative medical technologies for organ transplantation. Its flagship Organ Care System keeps donor organs viable during transport, improving transplant outcomes for heart, lung, liver and kidney recipients. It serves transplant centers and organ procurement organizations across North America, Europe and Asia-Pacific.

LCUT vs TMDX — Head-to-Head

Bigger by revenue
LCUT
LCUT
1.3× larger
LCUT
$204.1M
$160.8M
TMDX
Growing faster (revenue YoY)
TMDX
TMDX
+37.4% gap
TMDX
32.2%
-5.2%
LCUT
Higher net margin
TMDX
TMDX
56.7% more per $
TMDX
65.6%
8.9%
LCUT
More free cash flow
TMDX
TMDX
$16.4M more FCF
TMDX
$19.0M
$2.6M
LCUT
Faster 2-yr revenue CAGR
TMDX
TMDX
Annualised
TMDX
28.8%
19.8%
LCUT

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
LCUT
LCUT
TMDX
TMDX
Revenue
$204.1M
$160.8M
Net Profit
$18.2M
$105.4M
Gross Margin
38.6%
58.1%
Operating Margin
9.8%
13.2%
Net Margin
8.9%
65.6%
Revenue YoY
-5.2%
32.2%
Net Profit YoY
103.5%
1436.9%
EPS (diluted)
$0.83
$2.59

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
LCUT
LCUT
TMDX
TMDX
Q4 25
$204.1M
$160.8M
Q3 25
$171.9M
$143.8M
Q2 25
$131.9M
$157.4M
Q1 25
$140.1M
$143.5M
Q4 24
$215.2M
$121.6M
Q3 24
$183.8M
$108.8M
Q2 24
$141.7M
$114.3M
Q1 24
$142.2M
$96.8M
Net Profit
LCUT
LCUT
TMDX
TMDX
Q4 25
$18.2M
$105.4M
Q3 25
$-1.2M
$24.3M
Q2 25
$-39.7M
$34.9M
Q1 25
$-4.2M
$25.7M
Q4 24
$8.9M
$6.9M
Q3 24
$344.0K
$4.2M
Q2 24
$-18.2M
$12.2M
Q1 24
$-6.3M
$12.2M
Gross Margin
LCUT
LCUT
TMDX
TMDX
Q4 25
38.6%
58.1%
Q3 25
35.1%
58.8%
Q2 25
38.6%
61.4%
Q1 25
36.1%
61.5%
Q4 24
37.7%
59.2%
Q3 24
36.7%
55.9%
Q2 24
38.5%
60.6%
Q1 24
40.5%
61.9%
Operating Margin
LCUT
LCUT
TMDX
TMDX
Q4 25
9.8%
13.2%
Q3 25
3.9%
16.2%
Q2 25
-28.2%
23.2%
Q1 25
0.8%
19.1%
Q4 24
7.2%
7.1%
Q3 24
4.7%
3.6%
Q2 24
0.8%
10.9%
Q1 24
1.3%
12.8%
Net Margin
LCUT
LCUT
TMDX
TMDX
Q4 25
8.9%
65.6%
Q3 25
-0.7%
16.9%
Q2 25
-30.1%
22.2%
Q1 25
-3.0%
17.9%
Q4 24
4.1%
5.6%
Q3 24
0.2%
3.9%
Q2 24
-12.8%
10.7%
Q1 24
-4.4%
12.6%
EPS (diluted)
LCUT
LCUT
TMDX
TMDX
Q4 25
$0.83
$2.59
Q3 25
$-0.05
$0.66
Q2 25
$-1.83
$0.92
Q1 25
$-0.19
$0.70
Q4 24
$0.41
$0.19
Q3 24
$0.02
$0.12
Q2 24
$-0.85
$0.35
Q1 24
$-0.29
$0.35

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
LCUT
LCUT
TMDX
TMDX
Cash + ST InvestmentsLiquidity on hand
$4.3M
Total DebtLower is stronger
$135.0M
Stockholders' EquityBook value
$202.3M
$473.1M
Total Assets
$572.6M
$1.1B
Debt / EquityLower = less leverage
0.67×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
LCUT
LCUT
TMDX
TMDX
Q4 25
$4.3M
Q3 25
$12.1M
Q2 25
$12.0M
Q1 25
$10.4M
Q4 24
$2.9M
Q3 24
$6.0M
$330.1M
Q2 24
$3.4M
$362.8M
Q1 24
$4.6M
$350.2M
Total Debt
LCUT
LCUT
TMDX
TMDX
Q4 25
$135.0M
Q3 25
Q2 25
Q1 25
Q4 24
$142.5M
Q3 24
Q2 24
Q1 24
Stockholders' Equity
LCUT
LCUT
TMDX
TMDX
Q4 25
$202.3M
$473.1M
Q3 25
$184.6M
$355.2M
Q2 25
$185.8M
$318.1M
Q1 25
$225.7M
$266.3M
Q4 24
$229.9M
$228.6M
Q3 24
$220.9M
$209.9M
Q2 24
$219.8M
$189.9M
Q1 24
$223.7M
$159.5M
Total Assets
LCUT
LCUT
TMDX
TMDX
Q4 25
$572.6M
$1.1B
Q3 25
$581.1M
$946.0M
Q2 25
$551.9M
$890.5M
Q1 25
$594.6M
$837.5M
Q4 24
$634.3M
$804.1M
Q3 24
$668.7M
$785.6M
Q2 24
$617.0M
$758.6M
Q1 24
$602.7M
$723.8M
Debt / Equity
LCUT
LCUT
TMDX
TMDX
Q4 25
0.67×
Q3 25
Q2 25
Q1 25
Q4 24
0.62×
Q3 24
Q2 24
Q1 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
LCUT
LCUT
TMDX
TMDX
Operating Cash FlowLast quarter
$3.7M
$34.5M
Free Cash FlowOCF − Capex
$2.6M
$19.0M
FCF MarginFCF / Revenue
1.3%
11.8%
Capex IntensityCapex / Revenue
0.6%
9.7%
Cash ConversionOCF / Net Profit
0.21×
0.33×
TTM Free Cash FlowTrailing 4 quarters
$3.3M
$133.6M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
LCUT
LCUT
TMDX
TMDX
Q4 25
$3.7M
$34.5M
Q3 25
$-22.2M
$69.6M
Q2 25
$9.3M
$91.6M
Q1 25
$16.7M
$-2.9M
Q4 24
$20.3M
$19.7M
Q3 24
$-22.7M
$6.9M
Q2 24
$10.4M
$25.7M
Q1 24
$10.5M
$-3.4M
Free Cash Flow
LCUT
LCUT
TMDX
TMDX
Q4 25
$2.6M
$19.0M
Q3 25
$-22.7M
$61.9M
Q2 25
$8.2M
$82.5M
Q1 25
$15.1M
$-29.9M
Q4 24
$19.7M
$6.1M
Q3 24
$-23.2M
$-41.3M
Q2 24
$9.9M
$2.0M
Q1 24
$9.9M
$-47.6M
FCF Margin
LCUT
LCUT
TMDX
TMDX
Q4 25
1.3%
11.8%
Q3 25
-13.2%
43.1%
Q2 25
6.2%
52.4%
Q1 25
10.8%
-20.8%
Q4 24
9.1%
5.0%
Q3 24
-12.6%
-38.0%
Q2 24
7.0%
1.7%
Q1 24
7.0%
-49.2%
Capex Intensity
LCUT
LCUT
TMDX
TMDX
Q4 25
0.6%
9.7%
Q3 25
0.3%
5.3%
Q2 25
0.9%
5.8%
Q1 25
1.1%
18.8%
Q4 24
0.3%
11.2%
Q3 24
0.3%
44.3%
Q2 24
0.4%
20.8%
Q1 24
0.4%
45.6%
Cash Conversion
LCUT
LCUT
TMDX
TMDX
Q4 25
0.21×
0.33×
Q3 25
2.86×
Q2 25
2.62×
Q1 25
-0.11×
Q4 24
2.28×
2.87×
Q3 24
-65.89×
1.63×
Q2 24
2.11×
Q1 24
-0.28×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

LCUT
LCUT

Kitchenware$114.3M56%
Tableware$41.7M20%
Home Solutions$29.4M14%
Other$18.8M9%

TMDX
TMDX

Liver Product$127.0M79%
Heart Product$26.0M16%
Other$5.9M4%
Lung Product$1.9M1%

Related Comparisons